user1.arrisa.xyz
Open in
urlscan Pro
217.144.98.187
Public Scan
URL:
https://user1.arrisa.xyz/
Submission: On May 21 via automatic, source certstream-suspicious — Scanned from DE
Submission: On May 21 via automatic, source certstream-suspicious — Scanned from DE
Form analysis
0 forms found in the DOMText Content
* Careers * Contact Us * Donate * Subscribe * Home * About * About * Board of Directors * Senior Leadership * Financial Statements * Global Funding & Support * Our History: 1995-2021 * Our Work * Our Work * Discovery & Research * Antibody Translational Research Program * Human Immunology Laboratory * IAVI Neutralizing Antibody Center * Vaccine Design and Development Laboratory * Clinical Research Centers * Clinical Research Standards * Observational Epidemiology Studies * IAVI in Africa * Translation & Product Development * Global Access to Scientific Innovations * ADVANCE * IAVI DataSpace * Advocacy & Community Engagement * CASPR * Tuberculosis R&D Advocacy * World Bank/Japan-supported Partnerships | 日本政府・世銀が支援するパートナーシップ * Our Science * Our Science * Pipeline * HIV Vaccines * bnAbs for HIV Prevention * Tuberculosis Vaccines * Emerging Infectious Diseases Vaccines * News & Resources * Latest News * Scientific Publications * Press Releases * Features * IAVI Report * IAVI in the News * Fact Sheets & Publications * Vaccine Literacy Library * VOICES Newsletter * Multimedia * Media Contacts * Subscribe * Careers * Contact Us * Donate * Subscribe Toggle navigation * Decrease font size Increase font size Default font sizes * Bright contrast Dark contrast Grayscale Reset contrast * Keyboard Navigation * Toggle underline * Home * About * About * Board of Directors * Senior Leadership * Financial Statements * Global Funding & Support * Our History: 1995-2021 * Our Work * Our Work * Discovery & Research * Translation & Product Development * Global Access to Scientific Innovations * ADVANCE * Advocacy & Community Engagement * Our Science * Our Science * Pipeline * HIV Vaccines * bnAbs for HIV Prevention * Tuberculosis Vaccines * Emerging Infectious Diseases Vaccines * News & Resources * Latest News * Scientific Publications * Press Releases * Features * IAVI Report * IAVI in the News * Fact Sheets & Publications * Vaccine Literacy Library * VOICES Newsletter * Multimedia * Media Contacts * Subscribe * Translating scientific discoveries into affordable, globally accessible public health solutions * Translating scientific discoveries into affordable, globally accessible public health solutions * Translating scientific discoveries into affordable, globally accessible public health solutions * Translating scientific discoveries into affordable, globally accessible public health solutions * Translating scientific discoveries into affordable, globally accessible public health solutions * Translating scientific discoveries into affordable, globally accessible public health solutions * * * * * * * * * * * * LATEST NEWS ZENDAL AND IAVI ANNOUNCE EXPANDED AGREEMENT ON DEVELOPMENT OF MTBVAC IAVI PAPER ON STRENGTHENING PATHWAYS TO ACCELERATE GLOBAL ACCESS TO MABS IAVI REPORT: A VIEW FROM ZAMBIA ON HIV VACCINE RESEARCH IAVI REPORT: IMPROVING ACCESS TO VACCINES DANISH GOVERNMENT RENEWS SUPPORT FOR IAVI'S HIV PREVENTION PROGRAM MEET THE SCIENTIST ON THE CUSP OF DEVELOPING A NOVEL HIV VACCINE CANDIDATE WHAT WE DO WHAT WE DO DISCOVER new approaches to developing vaccines and antibodies for HIV, TB, emerging infectious diseases, and neglected diseases. ACCELERATE translational and clinical research through our laboratories in the U.S., India, and the U.K. BUILD CAPACITY in-country for researching vaccine candidates while strengthening local public health and scientific expertise. PARTNER with industry and enlist biopharma product development skills to develop innovative products tailored to target populations. SHARE IAVI’s resources with other innovators to help the global health community as a whole succeed. EXTEND IAVI’s core capabilities to solving disease prevention and treatment challenges. ABOUT About Board of Directors Senior Leadership Financial Statements Global Funding & Support Our History: 1995-2021 OUR WORK Our Work Discovery & Research Translation & Product Development Global Access to Scientific Innovations ADVANCE Advocacy & Community Engagement OUR SCIENCE Our Science Pipeline HIV Vaccines bnAbs for HIV Prevention Tuberculosis Vaccines Emerging Infectious Diseases Vaccines NEWS & RESOURCES Latest News Scientific Publications Press Releases Features IAVI Report IAVI in the News Fact Sheets & Publications Vaccine Literacy Library VOICES Newsletter Multimedia Media Contacts Subscribe Accessibility Compliance/RFPs Contact IAVI Privacy Policy Site Map Supplier Diversity Terms of Use ©2023 International AIDS Vaccine Initiative. International AIDS Vaccine Initiative®, IAVI®, and the IAVI logo® are registered trademarks of the International AIDS Vaccine Initiative, Inc. × DON’T MISS A THING Sign up to receive updates on IAVI‘s work and the latest news from the field SUBSCRIBE NOW